Company Filing History:
Years Active: 2017
Title: Matthew Collin Thor Fyfe: Innovator in Flaviviridae Research
Introduction
Matthew Collin Thor Fyfe is a notable inventor based in Chipping Norton, GB. He has made significant contributions to the field of medical research, particularly in the treatment of viral infections. His work focuses on innovative solutions for diseases associated with the Flaviviridae family of viruses.
Latest Patents
Matthew holds a patent for "Lysine demethylase inhibitors for diseases and disorders associated with Flaviviridae." This invention relates to methods and compositions aimed at treating or preventing infections caused by Flaviviridae, including hepatitis C virus infections. The patent highlights the use of an LSD1 inhibitor as a potential therapeutic agent.
Career Highlights
Matthew is currently employed at Oryzon Genomics S.A., where he continues to advance his research in the field of virology. His work at the company has positioned him as a key player in the development of innovative treatments for viral infections.
Collaborations
Matthew collaborates with Jonathan Alleman Baker, contributing to the advancement of their shared research goals. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Matthew Collin Thor Fyfe's contributions to the field of Flaviviridae research demonstrate his commitment to finding effective treatments for viral infections. His innovative patent and collaboration with fellow researchers highlight the ongoing efforts to combat these challenging diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.